Urothelial carcinoma of the urinary bladder is a heterogeneous disease with multiple
possible treatment modalities and a wide spectrum of clinical outcome. Treatment decisions …

Stage T1 bladder cancers invade the lamina propria of the bladder and, despite sharing
many of the genetic features of muscle-invasive bladder cancers, are classified as non …

Abstract High-grade T1 (HGT1) bladder cancer is the highest risk subtype of non–muscle-
invasive bladder cancer with unpredictable outcome and poorly understood risk factors …

Abstract The Genitourinary Pathology Society (GUPS) undertook a critical review of the
recent advances in bladder cancer focusing on important topics of high interest for the …

The paradigm of pathologic stage (pT) categorization in bladder cancer remains the depth of
invasion into the different histologic layers of the bladder wall. However, the approaches to …

Background To date, there has been limited synthesis of RWE studies in high-risk non-
muscle invasive bladder cancer (HR-NMIBC). The objective of this research was to conduct …

Pathological assessment of bladder cancer is becoming an increasingly complex task owing
to the growing availability of molecular data for different histological subtypes and the …

Aims En‐bloc transurethral resection (TUR) of bladder tumour (ERBT) is designed to provide
more accurate pathological diagnosis of specimens than conventional TUR of bladder …

Bladder cancer is the fifth most common cancer worldwide. 1 In Canada, the estimated
incidence for 2020 was of 12 200 new cases, with 2600 disease-related deaths during that …

Purpose To evaluate the prognostic value of substaging on oncological outcomes in patients
with T (or pT1) urothelial carcinoma of the bladder. Methods A literature search using …